These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8290014)

  • 21. Characterization of erythroid inhibiting factors (EIF) in patients with anemia of chronic renal failure.
    Radtke HW; Rege AB; LaMarche M; Fisher JW
    Proc Clin Dial Transplant Forum; 1979; 9():179-83. PubMed ID: 552040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The need for blood transfusions in intermittent hemodialysis].
    Hoier-Madsen K; Krogsgaard AR; Pedersen K
    Ugeskr Laeger; 1973 Oct; 135(40):2143-51. PubMed ID: 4789477
    [No Abstract]   [Full Text] [Related]  

  • 24. [New pathogenetic views on renal anemia].
    Lamperi S
    Minerva Nefrol; 1982; 29(2):61-70. PubMed ID: 6752763
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ; Kao RH; Cheng TY; Huang CC; Chang SL; Lee FN
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin activity in acutely uremic mice.
    Mirand EA; Gordon AD; Murphy GP
    J Med; 1975; 6(3-4):261-70. PubMed ID: 1059720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anemia associated with chronic renal failure and chronic dialysis.
    Hodgson S
    Nephrol Nurse; 1980; 2(3):43-6. PubMed ID: 6900910
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical effects of oral fluoxymesterone in patients with dialysis-controlled uremia.
    Lindholm DD; Fisher JW; Vieira JA; Dombeck DH; Bernal G; Lerthora J
    Trans Am Soc Artif Intern Organs; 1973; 19():475-83. PubMed ID: 4722764
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythropoietin and anemia in chronic renal failure.
    Pavlović-Kentera V; Clemons GK; Djukanović L; Biljanović-Paunovic L
    Exp Hematol; 1987 Aug; 15(7):785-9. PubMed ID: 3609182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different answer to recombinant human erythropoietin in anephric and non-anephric haemodialyzed patients.
    Buemi M; Allegra A; Aloisi C; Giacobbe MS; Frisina N
    Nephron; 1990; 56(2):218-9. PubMed ID: 2243581
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythropoietin kinetics in normal and uremic sheep.
    Mladenovic J; Eschbach JW; Koup JR; Garcia JF; Adamson JW
    J Lab Clin Med; 1985 Jun; 105(6):659-63. PubMed ID: 3998618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked improvement of erythropoiesis in an anephric patient.
    Pololi-Anagnostou L; Westenfelder C; Anagnostou A
    Nephron; 1981; 29(5-6):277-9. PubMed ID: 7322253
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM
    Nephron; 1987; 46(3):312-5. PubMed ID: 3627325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polycythaemia in a haemodialyzed anephric patient with hepatitis. Demonstration of erythropoietin secretion (author's transl)].
    Simon P; Boffa G; Ang KS; Menault M
    Nouv Presse Med; 1982 Apr; 11(18):1401-3. PubMed ID: 7079159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The variable role of erythropoietin deficiency in the pathogenesis of dialysis anaemia.
    Radtke HW; Erbes PM; Fassbinder W; Koch KM
    Proc Eur Dial Transplant Assoc; 1977; 14():177-83. PubMed ID: 600954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia].
    Mazerska M; Pawlak K; Azzadin A; Małyszko J; Małyszko J; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1992 Oct; 88(4):230-7. PubMed ID: 1488323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of bone marrow erythroid colony-forming cells (CFU-E) by serum from chronic anemic uremic rabbits (39874).
    Ohno Y; Fisher JW
    Proc Soc Exp Biol Med; 1977 Oct; 156(1):56-9. PubMed ID: 302949
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum immunoreactive erythropoietin in patients with end stage renal disease.
    Gimenez LF; Watson AJ; Spivak JL
    Prog Clin Biol Res; 1990; 352():493-504. PubMed ID: 2402519
    [No Abstract]   [Full Text] [Related]  

  • 39. Anemia, uremia and polyamines.
    Campbell RA
    Nephron; 1985; 41(3):299-301. PubMed ID: 4058630
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
    Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
    Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.